Paris, France is set to become the epicenter of interventional cardiovascular medicine from May 19 to 22, 2026, as the esteemed Palais de Congrès hosts EuroPCR, the premier international course renowned for advancing the field through education, innovation, and collaborative experience sharing. EuroPCR’s reputation is firmly rooted in decades of scientific endeavor and clinical practice, making this event a must-attend for medical professionals spanning the spectrum of experience—from novices and fellows to seasoned specialists and allied health professionals. Over four dynamic days, attendees will engage in an intensive educational journey designed to foster improved patient outcomes through cutting-edge knowledge exchange.
The core philosophy of EuroPCR 2026 is encapsulated by its theme, “Education saves lives: Preventing and solving complications.” This reflects a steadfast commitment to evidence-based interventional cardiology, underscoring how the unreserved sharing of scientific data and clinical expertise propels the field forward. The course is not static; under the expert guidance of Course Directors Thomas Cuisset, Nicolas Dumonteil, and Nieves Gonzalo, supported by PCR Chairman Bernard Prendergast and Honorary Chairman Jean Fajadet, the curriculum evolves continuously to reflect emerging science and best clinical practices. This ensures that EuroPCR remains at the forefront of cardiovascular education, accessible and beneficial to all strata of practitioners including researchers, innovators, and industry stakeholders.
This year’s event promises a staggering array of offerings, featuring over 500 educational sessions and more than 800 hours of program content. The faculty roster is exceptional, comprising over 3,000 experts and presenters who will share insights ranging from basic fundamentals to the most advanced techniques in interventional cardiology. The symposium is designed symbiotically to support a diverse learning environment where multidisciplinary professionals—from cardiologists to nurses and technologists—can gain practical skills and theoretical knowledge imperative to contemporary cardiovascular care.
One of the most compelling features of EuroPCR 2026 is its internationally networked LIVE Centers, which deliver 17 LIVE educational cases broadcast from top-tier institutions across Europe and the United States. These include the Cleveland Clinic in the UK, Clinique Pasteur in Toulouse, and the Leipzig Heart Centre in Germany, among others. These live demonstrations offer rare real-time insights into complex procedural decision-making and innovative interventional strategies, enabling practitioners to observe, question, and learn within the immediacy of clinical action.
EuroPCR 2026 also stands out for its inclusive representation of 76 national societies and working groups. These bodies contribute not only through 28 dedicated sessions but also via ongoing interaction during the conference, allowing for a vibrant exchange of global perspectives and the harmonization of interventional practices worldwide. This collaborative spirit extends into the course’s new components, notably the comprehensive CTO (chronic total occlusion) track and a dedicated Calcium Skills Lab, where cardiologists can refine their approach to these notoriously challenging lesion subsets through simulation and hands-on learning.
Innovation remains a cornerstone of EuroPCR’s ethos, and the 2026 edition heralds a sophisticated Innovation Hub engineered to catalyze cross-sector collaboration among clinicians, industry leaders, regulators, and entrepreneurs. Divided into five distinct zones, this hub features the Connecting Zone to facilitate networking and partnership formation, the Digital Innovation Display showcasing trailblazing technologies, and the Innovations Showroom where emerging devices and techniques are unveiled in real-world contexts. Additionally, the Innovation Theatre hosts six sessions specifically devoted to disruptive advances, complemented by the AI Lab—an initiative developed in partnership with PCR-TCT designed to explore the transformative potential of artificial intelligence in interventional cardiology.
Educational innovation extends beyond the Innovation Hub. EuroPCR’s signature learning formats—including simulation-based training, hands-on workshops, and dedicated imaging skills courses—offer unparalleled opportunities for participants to engage deeply with new methodologies and technologies. This commitment to experiential learning enhances procedural competence and confidence, equipping attendees to apply novel approaches in their clinical environments effectively.
The conference further nurtures the intergenerational transmission of knowledge through 18 case-based learning sessions meticulously constructed by pairing seasoned course facilitators with emerging young experts. This mentorship model embodies PCR’s dedication to preparing the next generation of cardiovascular specialists while ensuring that time-tested wisdom is passed on effectively. The peer-to-peer dynamic inherent in these sessions enriches the learning experience, turning clinical case discussions into transformative teaching moments.
EuroPCR 2026’s academic vigor is demonstrated by a record-breaking volume of submissions reflecting its global scientific prestige. Over 3,400 contributions include nearly 2,000 clinical cases—a 19% increase over the previous year—more than 1,100 abstracts representing a 9% rise, and 166 late-breaking trials, which grew by over 16%. These submissions illustrate the conference’s integral role as a platform for unveiling novel research, fostering critical discourse, and disseminating breakthrough findings in interventional cardiology.
Notably, the Innovation sessions continue to thrive, with a 70% surge in project submissions signaling growing enthusiasm for technological advancement within the cardiovascular community. Additionally, image submissions have risen by over 18%, underscoring the value of visual data in enhancing diagnostic accuracy and therapeutic strategy formulation. These upward trends highlight EuroPCR’s dynamic nature and its ability to engage a broad, multidisciplinary audience invested in pushing the boundaries of interventional cardiovascular science.
The EuroPCR journey begins even before the main conference, with specialized precursor events such as the PCR Fellows Course—tailored for early-career interventionalists—and PCR Innovators Day, which serves as a nexus for cutting-edge discovery and industry networking. For the first time, The Physiology Course (TPC) will be held in collaboration with EuroPCR, offering a concentrated, high-impact day focused on embedding coronary physiology into everyday clinical decision-making. These initiatives ensure that EuroPCR remains comprehensive, catering to various learning needs and professional aspirations across the cardiovascular spectrum.
As EuroPCR 2026 approaches, it is clear that it represents more than a conference; it is a transformative educational experience designed to arm practitioners with the latest scientific insights, practical skills, and collaborative opportunities essential for advancing patient care in the rapidly evolving landscape of interventional cardiology. The event promises an unparalleled fusion of tradition and innovation that will shape the future directions of cardiovascular medicine for years to come.
Subject of Research: Interventional Cardiovascular Medicine Education and Innovation
Article Title: EuroPCR 2026: Advancing Interventional Cardiovascular Medicine Through Unprecedented Education and Innovation
News Publication Date: Not specified
Web References: Not specified
References: Not specified
Image Credits: Not specified
Keywords: EuroPCR 2026, interventional cardiology, cardiovascular education, interventional cardiovascular medicine, LIVE Centers, Innovation Hub, CTO track, Calcium Skills Lab, simulation-based learning, coronary physiology, AI in cardiology, cardiovascular innovation
